The surrogate immunohistochemical marker, p16INK4a, is used in clinical practice to determine the high-risk human papillomavirus (HPV) status of oropharyngeal squamous cell carcinomas (OPSCC). The gene discussed is CDKN2A; the disease is oropharynx squamous cell carcinoma.